Immunome discovers spike/nonspike SARS-CoV-2 antibodies

By The Science Advisory Board staff writers

February 18, 2021 -- Immunome has isolated potent antibodies that are capable of neutralizing several SARS-CoV-2 variants, including the South African variant (B.1.351), in pseudovirus testing.

The company discovered these antibodies by analyzing serum from SARS-CoV-2 "super-responders" who recovered from COVID-19 and mounted a robust immune response to a broad range of viral targets.

In July 2020, the company was awarded a $13.3 million technology award from the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in collaboration with the Defense Health Agency.

Copyright © 2021

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter